Corporate Social Responsibility

Gilead Sciences Corporate Social Responsibility

Videos from this campaign

Content from this campaign

Philanthropy & Cause Initiatives

Gilead Announces Funding Initiative To Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.
Gilead Sciences, Inc. (Nasdaq: GILD) announced it is providing a total of $12.6 million in grant funding to 19 organizations working to improve the HIV landscape for Black women and girls in the United States.

Diversity & Inclusion

Gilead Sciences: National Black HIV/AIDS Awareness Day
This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”

Health & Healthcare

Gilead Sciences and Black HIV/AIDS Awareness Day: Taking Action Toward Meaningful Change
This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.”

Awards, Ratings & Rankings

Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC
Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has been named one of America’s Most JUST Companies.

Health & Healthcare

Gilead Sets Sights on Hepatitis C Elimination As It Marks 10 Years of Curative Therapies
Long-time liver specialist Carrie Frenette says she won’t ever forget the people she treated for hepatitis C (HCV) before 2013 – the year that the Food and Drug Administration (FDA) approved a Gilead medicine. The medicine was the first curative therapy for HCV.

Awards, Ratings & Rankings

Gilead Named One of Newsweek America’s Greatest Workplaces for Diversity
We’re proud to offer an inclusive culture that enables all people to do their best work, and we’re happy to be named one of Newsweek America’s Greatest Workplaces for Diversity for our efforts.

Health & Healthcare

From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease
The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead.

Innovation & Technology

Gilead Sciences: Art Captures the Experiences of Women Living With Metastatic Breast Cancer
For the past 30 years, Pilar Fernandez has navigated living with metastatic breast cancer. And while she’s faced a series of related health challenges, it hasn’t slowed her down.

Responsible Business & Employee Engagement

Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
When employees at Gilead’s recently opened New Jersey office need a place to meet, the “Cara” conference room is one such place they gather. Given the room’s namesake, it’s especially fitting when the topic at hand is the company’s oncology work.

Awards, Ratings & Rankings

Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year
Gilead Sciences, Inc. (Nasdaq: GILD) announced the company has once again been recognized as one of the most sustainable pharmaceutical companies according to the Dow Jones Sustainability World Index (DJSI World) for the third consecutive year.
Gilead Sciences

More from Gilead Sciences

  1. Corporate Social Responsibility
    Gilead Sciences Corporate Social Responsibility
  2. Age Positively
    Those who experienced the early days of the HIV/AIDS epidemic remember the generation we lost and the enduring impact that has had on our community...
  3. Gilead 2015 CSR Report
    Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...